Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Han BiomedicalROCO:6999 26 Interest Coverage is 61.26 as of Dec. 2025, which is 47% below its 10-year median of 115.46. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 376 Biotechnology companies, Han Biomedical ranks worse than 55.32% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Han Biomedical's
Operating Income
for the
six
months ended in Dec. 2025 was NT$13.2 Mil. Han Biomedical's Interest Expense for the
six
months ended in Dec. 2025 was NT$-0.2 Mil.
Han Biomedical's interest coverage for the quarter that ended in Dec. 2025 was 61.26.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Han Biomedical Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Han Biomedical's Interest Coverage or its related term are showing as below:
ROCO:6999'
s Interest Coverage Range Over the Past 10 Years
Min: 58.98 Med: 115.46 Max: 400.62
Current: 58.98
ROCO:6999's Interest Coverage is ranked worse than 55.32% of 376
companies
in the Biotechnology industry
Industry Median: 104.025
vs ROCO:6999: 58.98
Han Biomedical (ROCO:6999) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Han Biomedical Interest Coverage Related Terms
Han Biomedical Interest Coverage Historical Data
* Premium members only.
The historical data trend for Han Biomedical's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:6999 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Han Biomedical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Han Biomedical's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Han Biomedical (ROCO:6999) has a Interest Coverage of 61.26 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Han Biomedical and its competitors. This is 47% below median its historical median of 115.46. Over the past decade, Han Biomedical's Interest Coverage has ranged from 58.98 to 400.62. According to the industry distribution chart, Han Biomedical ranks #208 out of 376 companies in the Biotechnology industry, placing it in the top 55.3%.
Is Han Biomedical's Interest Coverage too high?
Han Biomedical's current Interest Coverage of 61.26 is 47% below median its 10-year median of 115.46. Over the past 10 years, this metric has ranged from a low of 58.98 to a high of 400.62. The Biotechnology industry median Interest Coverage is 104.03. Han Biomedical's value of 61.26 is 41.1% below this industry median. Based on the distribution chart, Han Biomedical ranks #208 out of 376 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #208 out of 376 companies for Interest Coverage. This places Han Biomedical in the lower half of its industry. The industry median Interest Coverage is 104.03. Han Biomedical's value of 61.26 is 41.1% below this benchmark. Historically, Han Biomedical's own Interest Coverage has ranged from 58.98 to 400.62 over the past decade. While the company's 10-year median is 115.46 vs. the industry median of 104.03, Han Biomedical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.03, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Han Biomedical's current Interest Coverage of 61.26 is 41.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Han Biomedical and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Han Biomedical's current Interest Coverage is 61.26, which is 47% below median its own 10-year median of 115.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Interest Coverage of 61.26. The current Interest Coverage is 61.26, which is 47% below median its 10-year median of 115.46 and 41.1% below the Biotechnology industry median of 104.03. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Interest Coverage is 61.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 
